In-depth articles on peptide research, reconstitution, and protocols.
GH secretagogue cost per mg by vial size: real EU price-index arithmetic across GHRP-2, GHRP-6, hexarelin, sermorelin, ipamorelin, CJC-1295 and tesamorelin.
Read more
GHRP-6 dosing charts for the 5mg and 10mg vials at 2mL and 3mL reconstitution: mg/mL, draw volume, U-100 units and doses per vial for 50 to 300mcg.
Read more
U-40 vs U-100 insulin syringes: 1 unit is 0.025mL on one and 0.01mL on the other. Worked peptide draws on both barrels, plus the 2.5x error in full.
Read more
Dihexa reconstitution needs DMSO, not BAC water alone. Walk the co-solvent decision plus concentration and syringe-unit math for the 5mg and 10mg vials.
Read more
Hexarelin dosing for 2mg and 5mg vials: reconstitution volumes, mg/mL, mcg per unit, U-100 draw volumes, doses per vial and the real per-mg cost gap between the two sizes.
Read more
Ipamorelin 10mg dose chart in U-100 units: 200mcg and 300mcg converted at 2mL, 3mL and 5mL reconstitution, with mg/mL, draw volumes and doses per vial.
Read more
Melanotan 2 10mg dose chart in syringe units: 250mcg, 500mcg and 1mg converted at 2mL and 5mL reconstitution, with mg/mL, draw volumes, doses per vial and cost per dose.
Read more
P21 dosing math for 5mg and 10mg vials: mg/mL, mcg per unit, and exactly where the same target dose lands on the marks of a U-100 insulin syringe barrel.
Read more
Retatrutide cost per mg by vial size: real EU price-index arithmetic, doses per vial at each titration rung, waste math, and where the ladder breaks even.
Read more
BAC water vs sterile water: benzyl alcohol buys 28 days of repeated entry, sterile water is single-use. How that in-use window caps your real doses per vial.
Read more
CJC-1295 Ipamorelin stack dosing protocol: the ~100mcg saturation dose, GHRH+GHRP synergy, timing, and mcg-to-units maths for the classic GH recomp stack.
Read more
Glutathione reconstitution math for 600mg and 1500mg vials: work in mg/mL, not insulin units. Worked examples, dilution volumes and a free dosing calculator.
Read more
Sermorelin dosing math for 2mg, 5mg and 10mg vials: reconstitution volume, mg/mL, mcg per unit, draw volumes, doses per vial and real EU cost per dose.
Read more
Tesamorelin + ipamorelin blend dosing math for the 15mg 2:1 vial: mg/mL per component, syringe units, and what a tesamorelin-target draw really delivers.
Read more
Work out how many vials a full peptide cycle needs: escalating and flat protocols costed end to end, with running totals, a wastage haircut and real EU prices.
Read more
IGF-1 LR3 100mcg vial dilution and dosing: reconstitution volumes, mcg per insulin unit, worked draw examples, and why acetic acid differs from BAC water.
Read more
How to convert IU to mg for compounds labelled in International Units: why the factor is per-substance, worked somatropin and hCG arithmetic, and the syringe units that follow.
Read more
Retatrutide dosing and reconstitution guide for the triple agonist GLP-1 (the King Kong of GLP-1s). Use the peptide calculator to get mg/mL, units, and draw volumes for 5-30mg vials.
Read more
SS-31 dosage chart for 5mg, 10mg and 50mg vials: reconstitution volume, mg/mL, mcg per unit and draw volumes for every common elamipretide research dose.
Read more
Tesamorelin 10mg and 20mg reconstitution: the full 2mL, 3mL and 5mL grid, mg/mL, mcg per unit and exact U-100 draws for every common research dose.
Read more
Liraglutide vs semaglutide dosing compared: the daily 0.6-3.0mg ladder against the weekly one, plus doses-per-vial math for 5mg and 10mg liraglutide vials.
Read more
SNAP-8 vs Argireline compared on presentation and dosing: 10mg vial reconstitution math, what a 10% label really contains, and molar-equivalence arithmetic.
Read more
HGH Fragment 176-191 is the C-terminal 'fat-burning fragment' of growth hormone. How HGH Frag works, how it differs from full GH and AOD-9604, and the research.
Read more
HGH Frag 176-191 vs AOD-9604 compared for fat-loss research: structure, stability, human trial history, and lipolysis rationale behind these lipolytic fragments.
Read more
How Melanotan 2 โ the 'Barbie peptide' / 'tan jab' โ is dosed in research: the loading vs maintenance phases, the role of UV, and why starting low matters for nausea.
Read more
Which markers actually move on GH secretagogues and GLP-1s, why a pre-protocol baseline is the whole point, and how to read a number without fooling yourself.
Read more
Melanotan 1 (afamelanotide) and Melanotan 2 โ the so-called 'Barbie peptide' โ both drive tanning, but differ sharply in receptor selectivity and side effects. Here is the comparison.
Read more
People report getting drunk faster on retatrutide. Slowed gastric emptying changes the rate alcohol reaches the small intestine, reshaping the whole curve.
Read more
Eloralintide (LY3841136) is a once-weekly amylin agonist selective for AMY1R, with a ~2-week half-life and 20.1% weight loss at 48 weeks in Phase 2.
Read more
Thymalin (Timalina) is a thymus-derived peptide bioregulator from the Khavinson tradition. A research-use guide to the thymic factor, its immune rationale, and how it differs from Thymosin Alpha-1.
Read more
A research overview of Khavinson short-peptide bioregulators โ Epitalon, Thymalin, Vilon and relatives โ the tissue-specificity idea, and what the evidence base looks like.
Read more
Retatrutide (the 'Triple G' triple agonist) vs semaglutide (Ozempic, the 'skinny jab'): one receptor vs three, the weight-loss gap, and where each stands.
Read more
A guide to Khavinson's bioregulator peptides: Timalina, Pinealon and Epitalon, what a brain bioregulator is, and what the Russian evidence really says.
Read more
Pentadeca Arginate (PDA) explained: it is the same 15-amino-acid sequence as BPC-157 in an arginate salt, not a new peptide. What the stability claim really means.
Read more
What bacteriostatic water actually is, why the 0.9% benzyl alcohol matters, how it differs from sterile water and saline, and how to tell a legitimate vial from a relabelled one.
Read more
How to reconstitute CJC-1295 and read the concentration maths โ and why the DAC and no-DAC forms change the volume you draw and how often you draw it.
Read more
Start three compounds at once and you learn nothing. How to introduce one variable at a time, set a baseline, choose a washout, and read the result honestly.
Read more
Semaglutide (Ozempic, the 'skinny jab') and tirzepatide (Mounjaro, the 'King Kong jab') compared: single vs dual receptor mechanism, weight-loss data, and dosing.
Read more
Pinealon (EDR peptide, Glu-Asp-Arg) is a Khavinson brain bioregulator studied for neuroprotection. Learn the biorregulador cerebral concept, Cytogen capsules, and nootropic peptide stacks.
Read more
Follistatin-344 vs FST-315 compared: how these two myostatin inhibitor splice variants differ in heparin binding, distribution, and the muscle-growth research rationale.
Read more
PT-141 (bremelanotide, the 'female Viagra') and Melanotan 2 (the 'Barbie peptide') are both melanocortin agonists that overlap on libido โ but differ on tanning.
Read more
A 2026 preprint mapped self-reported retatrutide experiences from 13,589 Reddit users. The profile inverts the trial data โ appetite increase, fatigue and energy lead.
Read more
ARA-290 (Cibinetide) is an EPO-derived nerve repair peptide and IRR agonist studied for small-fibre neuropathy. Research facts, sarcoidosis data, and dosing.
Read more
CJC-1295 and ipamorelin are often compared, but they act on different receptors and are studied together. Here is how they differ and why they complement each other.
Read more
Copper peptides โ led by GHK-Cu โ are a 2026 beauty and healing research trend. This guide covers what a copper peptide is, GHK-Cu's role, and the wider family.
Read more
A blend locks you into one ratio, but component peptides often need different schedules. When a pre-mixed vial is the right buy, and when separate vials win.
Read more
MariTide (maridebart cafraglutide) is Amgen's once-monthly obesity injectable that antagonizes GIP while agonizing GLP-1 โ the opposite GIP direction from tirzepatide.
Read more
Mitochondrial-derived peptides explained: how Humanin (HNG / S14G-Humanin), MOTS-c, and Epitalon combine as a longevity stack, plus the honest MDP evidence limits.
Read more
A research-focused look at tesamorelin dosing โ the standard 2mg daily figure, reconstitution maths for 2mg and 5mg vials, timing, and how it differs from the GH secretagogues.
Read more
VK2735 is Viking's GLP-1/GIP dual agonist in both injectable and oral tablet forms. See the VENTURE-2 oral data, VANQUISH-1 enrollment, and why an oral dual matters.
Read more
GHRP-2 is a potent growth hormone secretagogue. This guide covers its research dosing ranges, the saturation-dose concept, and its cortisol and appetite trade-offs.
Read more
No appetite suppression at all from the start is not a plateau. Work through underdosing, product quality, dosing math, storage and true non-response in that order.
Read more
Orforglipron (Foundayo) is an oral GLP-1 agonist that is not a peptide. See the ATTAIN and ACHIEVE-3 data and why no food or water rules apply.
Read more
Food noise is the intrusive stream of food thoughts many people describe fading on GLP-1s. Here's the brain mechanism behind it, verified against the research.
Read more
Same total weekly dose, split into two half-doses. What splitting does to peak and trough, why half-life decides whether it helps, and what it costs in practice.
Read more
A practical overview of GHK-Cu research dosing โ subcutaneous vs topical routes, concentration maths, and why the copper tripeptide's blue solution is expected.
Read more
Retatrutide reconstitution math for 10 mg, 30 mg and 40 mg vials: exact BAC water ratios, mg/mL concentrations, and insulin-syringe units for common doses.
Read more
Thymosin alpha-1 (Tฮฑ1) is an immune-modulating peptide marketed as Zadaxin in some countries. Here is what the mechanism, human research, and regulatory status actually show.
Read more
Orforglipron vs oral semaglutide compared: small molecule vs peptide chemistry, dosing rules, and the ACHIEVE-3 head-to-head trial's HbA1c and weight results.
Read more
There is no mg-for-mg conversion between semaglutide, tirzepatide, retatrutide and cagrilintide. Here is why equivalence tables are invented, and what to do instead.
Read more
What is humanin peptide? A guide to the mitochondrial-derived peptide linked to centenarian longevity, its BAX and STAT3 pathways, and the human trial gap.
Read more
Hexarelin is the most potent growth hormone secretagogue in the GHRP family. Learn how it works, why desensitisation matters, and its research dosing context.
Read more
What is SS-31 (elamipretide)? A research-focused guide to the mitochondria-targeting tetrapeptide that binds cardiolipin, its trials, and its safety framing.
Read more
GLP-1 fatty liver treatment now has FDA backing. See the ESSENCE, SYNERGY-NASH, and survodutide trial data behind semaglutide's 2025 MASH drug approval.
Read more
A missed peptide dose matters entirely according to half-life class. Short-acting: skip it. Weekly compounds: barely moves the level. Never double to catch up.
Read more
See how a peptide injector pen works: prefilled vs reusable formats, the dose dial mechanism, pen needles, and how it compares to a vial-and-syringe workflow.
Read more
Oral vs injectable semaglutide: 25 mg once-daily pills equal 175 mg a week versus 2.4 mg injected, a 70x dosing gap explained by absorption, not potency.
Read more
Some peptides refuse to go into plain bacteriostatic water. The reason is isoelectric point, and the fix is usually pH. Here is what gels, why, and what helps.
Read more
What is MOTS-c? A plain-language guide to the mitochondrial-derived peptide studied for metabolism, insulin sensitivity, AMPK and exercise-linked longevity signalling.
Read more
Bimagrumab semaglutide combination lost 22.1% body weight in the phase 2 BELIEVE trial, with 92.8% of that loss from fat mass and lean mass largely preserved.
Read more
CJC-1295 ipamorelin water retention explained: the GH-to-IGF-1-to-kidney pathway behind puffy hands, facial puffiness, and carpal-tunnel-like tingling.
Read more
Overfill, syringe dead space and residual volume mean a 10mg vial rarely yields the dose count you calculated. Here is the honest arithmetic, worked through.
Read more
DSIP (delta sleep-inducing peptide) is a nonapeptide studied for slow-wave sleep and stress modulation. Here is what the limited, largely dated research actually shows.
Read more
Tirzepatide sleep apnea data from SURMOUNT-OSA: Zepbound cut AHI by 25-29 events per hour and became the first FDA-approved drug for obstructive sleep apnea.
Read more
Zenagamtide (formerly amycretin) is a single 68-amino-acid peptide hitting both GLP-1 and amylin receptors, not a two-drug combo. ADA 2026 data explained.
Read more
What is AOD-9604? A research look at the HGH fragment (176-191) studied for fat metabolism, what the mixed clinical evidence shows, and how it differs from GLP-1s.
Read more
Semaglutide Alzheimer's trials EVOKE and EVOKE+ found no cognitive benefit at all, despite a 30% drop in CRP. Here's what the phase 3 trial data actually shows.
Read more
GLP-1 heart kidney data from SELECT and FLOW: semaglutide cut cardiovascular events 20% and kidney or CV events 24% in two landmark phase 3 outcome trials.
Read more
SLU-PP-332 is searched and sold as a peptide, but it's a synthetic small molecule. See the real molecular weight, ERR mechanism, and mouse-only evidence.
Read more
Tirzepatide dosing and titration explained: how the dual GIP/GLP-1 agonist is escalated in SURMOUNT and SURPASS trials, its dose-response on weight and A1c, and why.
Read more
GLP-1s and bone density in 2026: a 146,000-record AAOS analysis, an 11% fragility-fracture signal, ~2.6% hip BMD loss, and why lean mass and training matter.
Read more
Collagen peptides you drink and research peptides you inject share one word but nothing else โ dose, source, route, and regulatory category differ completely.
Read more
Stopping GLP-1 and weight regain explained: what STEP-1, STEP-4 and SURMOUNT-4 reveal about coming off semaglutide or tirzepatide and keeping results.
Read more
Oral semaglutide (the Wegovy pill) has an EMA CHMP recommendation and FDA approval. Here is what OASIS 4, SNAC absorption, and the four tablet strengths mean.
Read more
Follistatin-344 is studied as a myostatin and activin antagonist that removes the natural brake on muscle growth. Here is the mechanism and the honest evidence gap.
Read more
GHK-Cu topical vs injectable: the peer-reviewed evidence is overwhelmingly topical, not injectable. See the research gap, worked reconstitution math, and dosing
Read more
How semaglutide dosing and titration is structured in the clinical literature: the weekly step-up schedule, dose-response data, and the pharmacology behind slow escalation.
Read more
IGF-1 LR3 vs DES vs PEG-MGF compared: half-life, local vs systemic action, IGF-1R signalling, and why all three are evidence-poor research peptides.
Read more
ARA-290 (cibinetide) is a non-erythropoietic EPO-derived peptide studied for small-fiber neuropathy. Here is what the innate repair receptor and Phase 2 trials actually show.
Read more
Retatrutide dosing and titration explained: the phase 2 starting dose, the every-4-week ramp to 12 mg, the dose-response on weight, and why slow escalation limits nausea.
Read more
Retatrutide dysesthesia explained: the tingling and skin-sensation signal reported at 9 mg and 12 mg in TRIUMPH-1 and TRIUMPH-4, and what may explain it.
Read more
5-Amino-1MQ is a small-molecule NNMT inhibitor, not a peptide. See how blocking NNMT preserves NAD+ and SAM, shrinks fat cells in mice, and why human data is still zero.
Read more
FOXO4-DRI is a D-retro-inverso senolytic peptide that disrupts the FOXO4-p53 interaction to clear senescent cells. Here is what the preclinical evidence actually shows.
Read more
Amylin analogs work through a satiety pathway separate from GLP-1 โ how cagrilintide, petrelintide, and zenagamtide compare, and why every maker wants both.
Read more
Preventing muscle loss on GLP-1: what research says about protein (1.2-1.6 g/kg), resistance training, pacing, and the temporary hair shedding of rapid weight loss.
Read more
How peptide cycling works in research: why receptor desensitization drives on/off periods, representative cycles by class, and why GLP-1 tolerance is different.
Read more
Subcutaneous vs intramuscular for research peptides: how the two routes differ in absorption speed, peak level, and duration, plus needle and angle mechanics.
Read more
Peptides arrived warm and shipped without ice? Stability science explains why lyophilized powder shrugs off transit heat โ and when a vial is genuinely suspect.
Read more
PT-141 dosage in the RECONNECT trials came with real tradeoffs: nausea in 40% of users, flushing in 20%. What the Vyleesi label and trial data actually show.
Read more
Mod GRF 1-29 is CJC-1295 no-DAC: a stabilised GRF(1-29) analogue with a ~30 minute half-life that amplifies GH pulses rather than raising baseline GH.
Read more
What elimination half-life really means, why it drives dosing frequency, how steady state and accumulation work, and why many quoted peptide half-lives are unreliable.
Read more
Peptide reconstitution problems solved: why solutions go cloudy, clump, foam, or precipitate, plus a problem-cause-fix table for research-use vials in the EU.
Read more
Retatrutide phase 3 results from TRIUMPH-1: 28.3% average weight loss at 12 mg, 45.3% past the 30% mark, and a 104-week curve that hadn't flattened yet.
Read more
Mixing peptides in one syringe, one vial, or one pen cartridge are three different questions. Here's how contact time, pH, and co-storage actually decide the answer.
Read more
Nasal absorption is governed by molecular size and lipophilicity, not marketing. Which peptides genuinely work intranasally, which don't, and how to evaluate any spray claim.
Read more
MK-677 is not a peptide. A calm, accurate comparison of ibutamoren against ipamorelin, GHRP-2, CJC-1295 and sermorelin โ pulsatility, selectivity and evidence.
Read more
Peptide blend dosing made simple: a 15/15mg blend means 15mg of each compound (30mg total). Learn to compute concentration and per-peptide units.
Read more
Petrelintide is Zealand Pharma and Roche's long-acting amylin analog; Phase 2 ZUPREME-1 showed up to 10.7% weight loss with placebo-like tolerability.
Read more
How falling oestrogen changes the GLP-1 picture: visceral fat, insulin sensitivity, the muscle-and-bone compounding problem, and what the hormone therapy data actually shows.
Read more
Klotho is a real longevity protein with a serious literature. FLGR242 is not. A mellow, evidence-honest look at the community's favorite longevity-muscle stack.
Read more
GLP-1 knee osteoarthritis data from TRIUMPH-4: retatrutide cut WOMAC pain scores 74-76% and left some patients pain-free. Here's what the trial found.
Read more
NAD+ injections vs NMN/NR pills, worth it? What the research shows on raising NAD+, the dosing people discuss, and why flushing happens and how to slow it.
Read more
GHK-Cu is a copper complex, not a plain peptide โ which explains the blue colour, the slow dissolution, the injection-site welts, and why it should never share a vial.
Read more
Hair shedding on semaglutide and tirzepatide is now documented. Why it is telogen effluvium from rapid weight loss, the timeline, and how to get ahead of it.
Read more
Learn how many units your peptide dose is on a U-100 insulin syringe. Convert mcg/mg to units with clear reconstitution math and worked research examples.
Read more
Rotten-egg burps on tirzepatide or retatrutide are near-universal and mechanistically expected. Here is why slowed gastric emptying causes them and what actually stops them.
Read more
The cagrilintide + retatrutide stack adds the amylin pathway on top of a triple agonist. Here is the rationale, the one-vial vs two-vial question, and the tolerability logic.
Read more
How cagrilintide dosing and titration is structured in the amylin-analog literature: the weekly step-up ladder, where nausea peaks, and why benefit flattens at the top.
Read more
Kisspeptin and oxytocin peptide research explained: how kisspeptin drives GnRH/LH release and how oxytocin shapes bonding, with honest human-trial evidence.
Read more
Melanotan moles and new freckles explained: the MC1R mechanism behind darkening pigment, what case reports say, and the ABCDE checklist for a changing mole.
Read more
Why GLP-1s can raise gallstone risk, the warning signs of a gallbladder attack, when to hold a dose, and practical ways to lower the odds during fast weight loss.
Read more
How GLP-1s affect conception: why 'Ozempic babies' happen, the washout windows before trying, and why stopping before conception matters more than stopping after.
Read more
A peptide injection site reaction (PIP, redness, welt, blood in syringe) is usually harmless. Learn what is normal versus worth attention with subcutaneous research.
Read more
How the research community tapers off retatrutide instead of cold-stopping: stepping the dose down, spacing injections around the ~6-day half-life, and holding the loss.
Read more
A hands-on guide to independently testing your own peptide vial: what HPLC, MS, and quantity tests tell you, how to ship a sample to Janoshik, and how to verify the report is real.
Read more
How to tell if a peptide vendor is legit: spot scams, underdosing and fake COAs, verify third-party HPLC testing, and match the batch to your vial.
Read more
The GLOW peptide blend explained: the GHK-Cu, BPC-157 and TB-500 ratio, what KLOW adds, and the exact math behind every unit you draw.
Read more
Bimagrumab, apitegromab, trevogrumab and enobosarm are racing to stop the lean-mass loss GLP-1s cause. Here's what the 2025 trial readouts actually show.
Read more
A GLP-1 weight-loss plateau is normal, not failure. See what the trial data shows about why you stall on semaglutide or tirzepatide and how to restart.
Read more
GLP-1 side effects management explained: why semaglutide and tirzepatide cause nausea, sulfur burps, constipation and fatigue, plus what the research shows helps.
Read more
NMN vs NR: a 2026 crossover trial reportedly found NR raises blood NAD+ more than NMN. What's verified, what's industry-sourced, and why the gap exists.
Read more
GHRP-2 vs GHRP-6 compared: both are ghrelin-receptor agonists, but GHRP-6 drives strong hunger while GHRP-2 is more potent for GH release with less appetite.
Read more
Epithalon dosing and cycle explained: the commonly cited 10mg-for-10-days protocol, how often it repeats, and what telomerase and pineal research actually shows.
Read more
BPC-157 cancer risk explained through the 2025 Jรณzwiak-Sikiric debate over angiogenesis, VEGFR2/eNOS signaling, and the human tumor data that doesn't exist.
Read more
BPC-157 timeline and side effects explained: how long to work in the research, reported side effects, and why anxiety or mood shifts get reported so often.
Read more
The BPC-157 and TB-500 protocol explained: research-cited doses, the loading vs maintenance phase concept, and whether you can mix them in one vial.
Read more
Does tirzepatide affect birth control? Yes โ the Zepbound and Mounjaro label shows pill hormone levels drop after starting tirzepatide or stepping up a dose.
Read more
BPC-157 injection site explained: does local placement near the injury matter, or does the research suggest it acts systemically anywhere subcutaneous?
Read more
Retatrutide vs tirzepatide compared: receptor mechanisms, phase 2/3 trial weight-loss data, and why one is still early-stage. Research-use-only reference for EU readers.
Read more
Does semaglutide reduce alcohol cravings? Two randomized trials and rodent mechanism work suggest yes, though it remains unapproved for alcohol use disorder.
Read more
A dated 2026 peptide regulatory update: FDA removed 12 peptides from Category 2, the July PCAC reviewed 7 for the 503A bulks list, plus EU REACH context.
Read more
A research-only guide to peptide reconstitution and BAC water ratios: how the water-to-vial ratio sets concentration and injection precision, plus common mistakes to avoid.
Read more
A clear guide to peptide dosage math for research: mcg vs mg, what concentration means, converting a dose to insulin-syringe units, and why vial size shifts units.
Read more
Ipamorelin dosis and dosierung explained: selective GH secretagogue dosing patterns, fasted and pre-sleep timing, and how it compares to GHRP-2 and GHRP-6 in research.
Read more
A step-by-step peptide reconstitution calculator walkthrough: add BAC water, compute mg/mL concentration, and convert a target mcg into insulin-syringe units.
Read more
Research peptide legal status in the EU explained for 2026: how the REACH reagent framework, medicines law, and country-by-country enforcement in Germany, Spain, France, the Netherlands, and Nordics actually differ.
Read more
A research reference on the cjc-1295 ipamorelin blend: how a GHRH analog and a selective ghrelin-receptor secretagogue act on two pathways for a cleaner GH pulse.
Read more
CJC-1295 DAC vs no DAC compared: DAC binds albumin for a multi-day half-life, while Mod GRF 1-29 acts in ~30 minutes and preserves GH pulsatility.
Read more
BPC-157 oral vs injectable: how each route affects absorption and stability, and what the mostly-animal research shows about gut-local versus systemic effects.
Read more
Tesamorelin is an FDA-approved, stabilized GHRH analog studied for its effects on visceral fat and the GH/IGF-1 axis โ here is the mechanism, evidence, and research context.
Read more
Retatrutide (LY3437943) is an investigational triple-receptor agonist studied for its effects on body weight and metabolism; here is what the research shows so far.
Read more
PT-141 (bremelanotide) is a melanocortin receptor agonist studied for its central-nervous-system effects on sexual desire and arousal, distinct from the approved drug Vyleesi.
Read more
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme, not a peptide, central to redox metabolism, sirtuin and PARP signaling, and mitochondrial function โ here is what current research actually shows about its role in aging biology.
Read more
An evidence-based overview of Melanotan II (MT-II), a non-selective melanocortin receptor agonist studied for melanogenesis, including its mechanism, research background, and documented safety concerns.
Read more
KPV is the C-terminal tripeptide of alpha-MSH studied in preclinical models of intestinal inflammation and wound healing โ here is what the research shows about its mechanism and evidence base.
Read more
GHK-Cu is a naturally occurring copper-binding tripeptide studied for its roles in collagen synthesis, antioxidant defense, and wound-healing research.
Read more
Epithalon (Epitalon, AEDG) is a synthetic pineal tetrapeptide studied for telomerase activation and circadian melatonin regulation โ here is what the preclinical and limited human evidence actually shows.
Read more
CagriSema pairs the amylin analog cagrilintide with the GLP-1 agonist semaglutide in a single fixed-dose combination โ here is what the REDEFINE and phase 2 trial data show.
Read more
Cagrilintide is a once-weekly amylin/calcitonin receptor agonist studied for satiety and weight regulation, alone and combined with semaglutide as CagriSema.
Read more
A research-focused, head-to-head comparison of survodutide (BI 456906) and mazdutide (IBI362/LY3305677), the two leading GLP-1/glucagon dual-receptor agonist peptides.
Read more
A research-focused comparison of Selank (a tuftsin analog studied for anxiolytic and GABA/BDNF effects) and Semax (an ACTH(4-10) analog studied for BDNF/NGF-driven cognition and neuroprotection).
Read more
Explore the pipeline of weight loss peptides beyond Semaglutide and Tirzepatide, including Retatrutide, CagriSema, Orforglipron, and Survodutide. What's coming and what it means for research.
Read more
Navigate the peptide market confidently in 2026. Learn about quality indicators, what to look for in suppliers, third-party testing, and how to identify reputable sources.
Read more
Everything you need to know about GLP-1 microdosing - what it is, why people do it, the research behind it, and important safety considerations for Semaglutide and Tirzepatide.
Read more
Explore the emerging science of mitochondrial peptides including MOTS-c, SS-31, Humanin, and 5-Amino-1MQ. Learn why these compounds are dominating peptide research in 2026.
Read more
Complete guide on transitioning research protocols from Semaglutide to Tirzepatide, including dose conversion, timing, and what to expect during the switch.
Read more
Guide to popular peptide combinations - healing stacks, GH stacks, and synergistic protocols used in research settings.
Read more
Comprehensive comparison of the three major incretin peptides - mechanisms, efficacy, dosing protocols, and key differences for research purposes.
Read more
BPC-157 is a synthetic pentadecapeptide derived from human gastric juice. Learn about its research applications, mechanism of action, and why researchers are interested in this fascinating peptide.
Read more
Complete guide to storing peptides correctly - temperatures, stability, shelf life, and common storage mistakes to avoid for optimal research results.
Read more
Semaglutide is a GLP-1 receptor agonist that has gained significant attention in metabolic research. Learn about its mechanism, research applications, and why it's become so popular.
Read more
Learn proper subcutaneous injection technique for peptide research - site selection, needle angles, rotation schedules, and how to minimize discomfort.
Read more
Tirzepatide is a novel dual-action peptide targeting both GIP and GLP-1 receptors. Learn why this 'twincretin' has revolutionized metabolic peptide research.
Read more
In-depth comparison of the two most popular healing peptides - mechanisms, dosing, stacking, and when to use each for tissue repair research.
Read more
Ipamorelin is a selective growth hormone secretagogue that produces clean GH pulses without affecting cortisol or prolactin. Learn why researchers prefer this peptide.
Read more
Learn the fundamentals of peptide reconstitution including choosing the right water, proper technique, storage requirements, and common mistakes to avoid.
Read more
Learn how to read Certificates of Analysis, understand purity testing methods, and identify quality peptide suppliers for reliable research.
Read more
Complete introduction to peptide research - what peptides are, common types, how to handle them, equipment needed, and getting started safely.
Read more
TB-500 is a synthetic fragment of Thymosin Beta-4 researched for tissue repair and recovery. Learn about its mechanism, dosing protocols, and research applications.
Read more
Sermorelin is a growth hormone releasing hormone (GHRH) analog that stimulates natural, pulsatile GH release. Learn about its mechanism and why it's preferred for GH research.
Read moreNo peptides found